| Is there a role for alpha1-blockers in treating double-J stent-related symptoms? C Deliveliotis, M Chrisofos, E Gougousis, A Papatsoris, A Dellis, ... Urology 67 (1), 35-39, 2006 | 191 | 2006 |
| Risk assessment in sepsis: a new prognostication rule by APACHE II score and serum soluble urokinase plasminogen activator receptor EJ Giamarellos-Bourboulis, A Norrby-Teglund, V Mylona, A Savva, ... Critical care 16, 1-10, 2012 | 186 | 2012 |
| Laparoscopic ureterolithotomy: the Edinburgh experience Keeley, Gialas, Pillai, Chrisofos, Tolley BJU international 84 (7), 765-769, 1999 | 170 | 1999 |
| Urinary diversion in high-risk elderly patients: modified cutaneous ureterostomy or ileal conduit? C Deliveliotis, A Papatsoris, M Chrisofos, A Dellis, C Liakouras, ... Urology 66 (2), 299-304, 2005 | 138 | 2005 |
| The long‐term outcome after laparoscopic nephroureterectomy: a comparison with open nephroureterectomy SA McNeill, M Chrisofos, DA Tolley BJU international 86 (6), 619-623, 2000 | 138 | 2000 |
| Procalcitonin as an early indicator of outcome in sepsis: a prospective observational study EJ Giamarellos-Bourboulis, I Tsangaris, T Kanni, M Mouktaroudi, ... Journal of Hospital Infection 77 (1), 58-63, 2011 | 108 | 2011 |
| Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial … A Bamias, U Dafni, A Karadimou, E Timotheadou, G Aravantinos, A Psyrri, ... Annals of oncology 24 (4), 1011-1017, 2013 | 101 | 2013 |
| Does the management of bladder perforation during transurethral resection of superficial bladder tumors predispose to extravesical tumor recurrence? A Skolarikos, M Chrisofos, N Ferakis, A Papatsoris, A Dellis, C Deliveliotis The Journal of urology 173 (6), 1908-1911, 2005 | 92 | 2005 |
| Progression into sepsis: an individualized process varying by the interaction of comorbidities with the underlying infection D Sinapidis, V Kosmas, V Vittoros, IM Koutelidakis, A Pantazi, A Stefos, ... BMC infectious diseases 18, 1-9, 2018 | 80 | 2018 |
| Management and follow-up of impacted ureteral stones C Deliveliotis, M Chrisofos, S Albanis, E Serafetinides, J Varkarakis, ... Urologia internationalis 70 (4), 269-272, 2003 | 79 | 2003 |
| Finasteride effects on hypoxia and angiogenetic markers in benign prostatic hyperplasia AG Lekas, AC Lazaris, M Chrisofos, AG Papatsoris, D Lappas, ... Urology 68 (2), 436-441, 2006 | 63 | 2006 |
| The novel prostate cancer antigen 3 (PCA3) biomarker A Bourdoumis, AG Papatsoris, M Chrisofos, E Efstathiou, A Skolarikos, ... International braz j urol 36, 665-669, 2010 | 62 | 2010 |
| The expression of hypoxia-inducible factor-1α (HIF-1α) and angiogenesis markers in hyperplastic and malignant prostate tissue A Lekas, AC Lazaris, C Deliveliotis, M Chrisofos, C Zoubouli, D Lapas, ... Anticancer research 26 (4B), 2989-2993, 2006 | 61 | 2006 |
| Can prostate biopsies affect erectile function? M Chrisofos, AG Papatsoris, A Dellis, IM Varkarakis, A Skolarikos, ... Andrologia 38 (3), 79-83, 2006 | 61 | 2006 |
| Oleuropein: A novel immunomodulator conferring prolonged survival in experimental sepsis by: Pseudomonas aeruginosa EJ Giamarellos-Bourboulis, T Geladopoulos, M Chrisofos, P Koutoukas, ... Shock 26 (4), 410-416, 2006 | 59 | 2006 |
| Biweekly carboplatin/gemcitabine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: report of efficacy, quality of life and geriatric … A Bamias, G Lainakis, E Kastritis, N Antoniou, G Alivizatos, A Koureas, ... Oncology 73 (5-6), 290-297, 2008 | 57 | 2008 |
| Prognostic significance of cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma treated with first-line sunitinib: a European … A Bamias, K Tzannis, A Papatsoris, S Oudard, B Beuselinck, B Escudier, ... Clinical genitourinary cancer 12 (5), 373-383, 2014 | 55 | 2014 |
| Diagnostic efficacy of transrectal ultrasound-guided biopsy of the prostatic fossa in patients with rising PSA following radical prostatectomy C Deliveliotis, T Manousakas, M Chrisofos, A Skolarikos, A Delis, ... World journal of urology 25, 309-313, 2007 | 54 | 2007 |
| Tamsulosin versus transurethral resection of the prostate: effect on nocturia as a result of benign prostatic hyperplasia V Simaioforidis, AG Papatsoris, M Chrisofos, M Chrisafis, S Koritsiadis, ... International journal of urology 18 (3), 243-248, 2011 | 49 | 2011 |
| Time to castration resistance is an independent predictor of castration-resistant prostate cancer survival E Bournakis, E Efstathiou, A Varkaris, S Wen, M Chrisofos, C Deliveliotis, ... Anticancer research 31 (4), 1475-1482, 2011 | 48 | 2011 |
